A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients

por Böhme, Angelika, Bergmann, L., Hoelzer, D., Just-Nübling, G., Shah, P. M., Stille, W.
Publicado 1995

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations

por Neumann, M, Heesch, S, Gökbuget, N, Schwartz, S, Schlee, C, Benlasfer, O, Farhadi-Sartangi, N, Thibaut, J, Burmeister, T, Hoelzer, D, Hofmann, W-K, Thiel, E, Baldus, C D
Publicado 2012

FAT1 expression and mutations in adult acute lymphoblastic leukemia

por Neumann, M, Seehawer, M, Schlee, C, Vosberg, S, Heesch, S, von der Heide, E K, Graf, A, Krebs, S, Blum, H, Gökbuget, N, Schwartz, S, Hoelzer, D, Greif, P A, Baldus, C D
Publicado 2014

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

por Gökbuget, N, Kelsh, M, Chia, V, Advani, A, Bassan, R, Dombret, H, Doubek, M, Fielding, A K, Giebel, S, Haddad, V, Hoelzer, D, Holland, C, Ifrah, N, Katz, A, Maniar, T, Martinelli, G, Morgades, M, O'Brien, S, Ribera, J-M, Rowe, J M, Stein, A, Topp, M, Wadleigh, M, Kantarjian, H
Publicado 2016